ADVERUM BIOTECHNOLOGIES INC (ADVM) Stock Analyst Earnings Estimates
NASDAQ:ADVM - Nasdaq - US00773U2078 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.5M | -100.00% | 3.6M | 1.02M -71.67% | 14.717M 1,342.84% | 460.53K -96.87% | 26.695M 5,696.58% | 12.903M -51.67% | 41.146M 218.89% | 108.53M 163.77% | 185.65M 71.06% | 301.79M 62.56% | |
| EBITDA YoY % growth | -140.377M -23.36% | -148.507M -5.79% | -118.147M 20.44% | -111.18M 5.90% | -165.24M -48.62% | -189.72M -14.81% | -236.64M -24.73% | -313.14M -32.33% | -367.2M -17.26% | -354.96M 3.33% | -291.72M 17.82% | -184.62M 36.71% | |
| EBIT YoY % growth | -145.022M -22.95% | -155.035M -6.90% | -123.791M 20.15% | -110.859M 10.45% | -129.643M -16.94% | -140.349M -8.26% | -161.939M -15.38% | -188.551M -16.43% | -200.164M -6.16% | -156.634M 21.75% | -101.614M 35.13% | -11.86M 88.33% | |
| Operating Margin | -1,933.63% | N/A | -3,438.64% | -10,868.56% | -880.91% | -30,475.53% | -606.63% | -1,461.29% | -486.47% | -144.32% | -54.73% | -3.93% | |
| EPS YoY % growth | -14.80 -8.03% | -15.50 -4.73% | -11.60 25.16% | -5.11 55.91% | -4.77 6.72% | -4.25 11.01% | -3.84 9.54% | -4.03 -4.83% | -3.21 20.19% | -2.06 35.77% | -0.45 78.09% | 1.30 386.49% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.39 39.74% | -1.38 8.05% | -1.44 -61.30% | -1.34 -3.46% | -1.26 9.40% |
| Revenue Q2Q % growth | -100.00% | ||||
| EBITDA Q2Q % growth | -32.64M -60.68% | -34.68M -34.20% | -38.76M -104.77% | -43.86M -66.27% | -47.94M -46.88% |
| EBIT Q2Q % growth | -32.965M -26.99% | -34.082M -26.99% | -36.436M -74.49% | -39.063M -33.68% | -41.503M -25.90% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.30 60.61% | -1.33 | 0.03 | 2.50% |
| Q2 2024 Q2Q % growth | -0.89 71.29% | -1.50 | 0.61 | 40.56% |
| Q1 2024 Q2Q % growth | -1.50 48.28% | -1.43 | -0.07 | -4.70% |
| Q4 2023 Q2Q % growth | -2.30 30.30% | -3.43 | 1.13 | 33.02% |
| Q3 2023 Q2Q % growth | -3.30 17.50% | -3.21 | -0.09 | -2.65% |
| Q2 2023 Q2Q % growth | -3.10 29.55% | -3.35 | 0.25 | 7.57% |
| Q1 2023 Q2Q % growth | -2.90 23.68% | -3.27 | 0.37 | 11.26% |
| Q4 2022 Q2Q % growth | -3.30 5.71% | -3.70 | 0.40 | 10.73% |
| Q3 2022 Q2Q % growth | -4.00 -2.56% | -3.52 | -0.48 | -13.67% |
| Q2 2022 Q2Q % growth | -4.40 2.22% | -3.47 | -0.93 | -26.87% |
| Q1 2022 Q2Q % growth | -3.80 -31.03% | -3.16 | -0.64 | -20.18% |
| Q4 2021 Q2Q % growth | -3.50 10.26% | -3.50 | 0.00 | 0.06% |
| Q3 2021 Q2Q % growth | -3.90 -25.81% | -3.83 | -0.07 | -1.96% |
| Q2 2021 Q2Q % growth | -4.50 -25.00% | -3.97 | -0.53 | -13.45% |
| Q1 2021 Q2Q % growth | -2.90 6.45% | -3.89 | 0.99 | 25.40% |
| Q4 2020 Q2Q % growth | -3.90 -34.48% | -3.29 | -0.61 | -18.38% |
| Q3 2020 Q2Q % growth | -3.10 -24.00% | -3.50 | 0.40 | 11.48% |
| Q2 2020 Q2Q % growth | -3.60 -56.52% | -2.89 | -0.71 | -24.57% |
| Q1 2020 Q2Q % growth | -3.10 -34.78% | -2.79 | -0.31 | -10.92% |
| Q4 2019 Q2Q % growth | -2.90 | -3.00 | 0.10 | 3.39% |
| Q3 2019 Q2Q % growth | -2.50 | -2.70 | 0.20 | 7.26% |
| Q2 2019 Q2Q % growth | -2.30 | -3.00 | 0.70 | 23.30% |
| Q1 2019 Q2Q % growth | -2.30 | -2.74 | 0.44 | 16.05% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1M | 102K | 898K | 880.39% |
| Q2 2024 Q2Q % growth | 77.224K | -77.224K | -100.00% | |
| Q1 2024 Q2Q % growth | -100.00% | 74.317K | -74.317K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | 7.5M | 58.65K | 7.441M | 12,687.72% |
| Q4 2020 Q2Q % growth | 78.203K | -78.203K | -100.00% | |
| Q3 2020 Q2Q % growth | -100.00% | 67.024K | -67.024K | -100.00% |
| Q2 2020 Q2Q % growth | 96.9K | -96.9K | -100.00% | |
| Q1 2020 Q2Q % growth | 86.129K | -86.129K | -100.00% | |
| Q4 2019 Q2Q % growth | 146.197K | -146.197K | -100.00% | |
| Q3 2019 Q2Q % growth | 250K | 180.203K | 69.797K | 38.73% |
| Q2 2019 Q2Q % growth | 308.04K | -308.04K | -100.00% | |
| Q1 2019 Q2Q % growth | 316.2K | -316.2K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2.17% | 0% | 1.06% |
| Revenue | N/A | N/A | 0% | 60% |